Early research (Phase 1)Study completedNCT02675478What this trial is testingPhase 1 Study of QuizartinibWho this might be right forRelapsed AMLRefractory AML Daiichi Sankyo Co., Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT00053287What this trial is testingFludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Case Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416984What this trial is testingSafety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)Who this might be right forRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Allogene Therapeutics 160
Testing effectiveness (Phase 2)Study completedNCT04173585What this trial is testingTEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With BortezomibWho this might be right forAcute Myeloid Leukemia University Hospital Heidelberg 50
Testing effectiveness (Phase 2)UnknownNCT04502394What this trial is testingSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLLWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Kartos Therapeutics, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT01126814What this trial is testingImatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid LeukemiaWho this might be right forLeukemia University Health Network, Toronto 35
Early research (Phase 1)Ended earlyNCT02267863What this trial is testingAPTO-253 in Patients With Relapsed or Refractory AML or MDSWho this might be right forAcute Myelogenous Leukemia in RelapseAcute Myelogenous Leukemia, Relapsed, AdultAcute Myelogenous Leukemia, Adult+2 more Aptose Biosciences Inc. 21
Testing effectiveness (Phase 2)WithdrawnNCT03207334What this trial is testingICare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)Who this might be right forAcute Myeloid Leukemia University of Florida
Testing effectiveness (Phase 2)Study completedNCT00481871What this trial is testingStudy of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesWho this might be right forRelapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more Acrotech Biopharma Inc. 119
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Testing effectiveness (Phase 2)Study completedNCT00003340What this trial is testingCyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Very early researchStudy completedNCT03825718What this trial is testingGC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Hebei Yanda Ludaopei Hospital 29
Early research (Phase 1)Looking for participantsNCT04881240What this trial is testingStudy of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL St. Jude Children's Research Hospital 60
Early research (Phase 1)Ended earlyNCT02635074What this trial is testingIbrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Adult Acute Myeloid Leukemia Steven E. Coutre 2
Early research (Phase 1)UnknownNCT03825146What this trial is testingThe Effects of AMPC in the Treatments of Refractory or Relapsed AMLWho this might be right forAcute Myeloid Leukaemia Recurrent Lai Corporation Pty. Ltd. 10
Early research (Phase 1)Study completedNCT01174888What this trial is testingPhase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia FollowingMyelodysplastic Syndrome+8 more Alison Walker 34
Post-approval studies (Phase 4)UnknownNCT00196768What this trial is testingTreatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With ArsenicWho this might be right forRelapsed Acute Promyelocytic LeukemiaRefractory Acute Promyelocytic Leukemia German AML Cooperative Group 30